Clinical studies have found that the active ingredient dihydrotanshinone I in Salvia miltiorrhiza can inhibit GPX4 expression in breast cancer cells, promote ferroptosis, and inhibit tumor growth in mice without significant side effects (102). The gene discussed is GPX4; the disease is breast carcinoma.